BaillyR.LauwerysR.BucherJ. P.MahieuP.KoningsJ. (1991). Experimental and human studies on antimony metabolism: Their relevance for the biological monitoring of workers exposed to inorganic antimony. Br. J. Indust. Med. 48, 93–97.
2.
BermanJ. D.GallalerJ. F.GallalerJ. V. (1988). Pharmacokinetics of pentavalent antimony (Pentostan) in hamsters. Am. J. Trop. Med. Hyg. 39, 41–45.
3.
ChertokR. J.LakeS. (1970). Availability in the dog of radionuclides in nuclear debris from the Plowshare excavation Cabriolet. Health Phys. 19, 405–409.
4.
CoughtreyP. J.ThorneM. C. (1983). Radionuclide Distribution and Transport in Terrestrial and Aquatic Ecosystems, Vol. 3 (BalkemaA. A. ed.), Rotterdam.
5.
DjurićD.ThomasR. G.LieR. (1962). The distribution and excretion of trivalent antimony in the rat following inhalation. Int. Arch. Gewerbepathol. Gewerbehyg. 19, 529–545.
6.
FelicettiS. A.ThomasR. G.McClellanR. O. (1974a). Metabolism of two valence states of inhaled antimony in hamsters. Am. Ind. Hyg. Assoc. J. 35, 292–300.
7.
FelicettiS. A.ThomasR. G.McClellanR. O. (1974b). Retention of inhaled antimony-124 in the beagle dog as a function of temperature of aerosol formation. Health Phys. 26, 525–531.
8.
ICRP (1981). Limits for Intakes of Radionuclides by Workers. ICRP Publication 30, Part 3. Annals of the ICRP6(2/3), Pergamon Press, Oxford.
9.
InabaJ.NishimuraY.IchikawaR. (1984a). Studies on the metabolism of antimony-125 in the rat. NIRS-N-49 (National Institute of Radiological Sciences, Chiba, Japan), 81–83.
10.
InabaJ.NishimuraY.IchikawaR. (1984b). Effect of age on the metabolism of some important radionuclides in the rat. In: Radiation Risk Protection. Proc. 6th Int. Congr. of IRPA, Vol. 1, pp. 481–484 (KaulA.NeiderR.PenskoJ.StieveF. E.BrunnerH. eds.) Fachverband für Strahlenschutz e. V., Berlin.
11.
IyengarG. V.KellnerW. E.BauerH. J. M. (1978). The Elemental Composition of Human Tissues and Body Fluids. Verlag Chemie, Weinheim.
12.
MoskalevY. I. (1964). Experiments dealing with distribution of antimony-124 and tellurium-127. AEC-tr-7590, pp. 63–72.
13.
NEA/OECD (1988). Committee on Radiation Protection and Public Health. Report of an Expert Group on Gut Transfer Factors. NEA/OECD, Paris.
14.
RoseE.JacobsH. (1969). Whole-body counter and bioassay results after an acute antimony-126 exposure. IAEA-SM-119/30, pp. 269–280.
15.
TarrantM. E.WadleyS.WoodageJ. J. (1971). The effect of penicillamine on the treatment of experimental schistosomiasis with tartar emetic. Ann. Trop. Med. Parasitol. 65, 233–244.
16.
ThomasR. G.FelicettiS. W.LuchinoR. V.McClellanR. O. (1973). Retention patterns of antimony in mice following inhalation of particles formed at different temperature. Proc. Soc. Exp. Biol. Med. 144, 544–550.
17.
Van BruwaeneR.GerberG. B.KirchmannR.ColardK. (1982). Metabolism of antimony-124 in lactating dairy cows. Health Phys. 43, 733–738.
18.
WaitzJ. A.OberR. E.MeisenholderJ. E.ThompsonP. E. (1965). Physiological disposition of antimony after administration of 124Sb-labelled tartar emetic to rat, mice and monkeys, and the effects of tris (p-aminophenyl) carbonium pamoate on this distribution. Bull. W.H.O.33, 537–546.